Use "Flozins" Second-Line for Type 2 Diabetes
The American Diabetes Assn will endorse more drug combo choices for patients with type 2 diabetes.
Metformin plus lifestyle changes will remain first-line...but most type 2s will need 2 or more meds to reach glycemic goals.
SGLT2 inhibitors or "flozins" (Invokana, etc) will be a new second-line choice...along with sulfonylureas, glitazones (Actos, etc), gliptins (Januvia, etc), GLP-1 agonists (Victoza, etc), and insulin.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote